Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HRS-9190 for tracheal intubation during general anesthesia
NCT07252921Phase 2Completed
- Sponsor
- Hengrui
- Start
- Oct 2025
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of HRS-9190 in neuromuscular blockade (NMB) (3 arms), sponsored by Hengrui. Primary endpoint: Intubation conditions. Started Oct 2025; status: completed.
02
Drugs
HRS-9190
03
Conditions
neuromuscular blockade (NMB)
Beyond the preview
Go deeper on NCT07252921.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07252921.